XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Total revenue $ 145 $ 511
Cost of sales 132 344
Gross profit 13 167
Operating expenses:    
Research and development 901 3,047
Management contingent share plan (732) 10,091
Impairments of intangible assets and cloud computing arrangements 2,633 1,370
Selling, general and administrative 19,399 25,826
Total operating expenses 22,201 40,334
Loss from operations (22,188) (40,167)
Non-cash change in fair value of convertible debentures (28,180)
Change in fair value of warrant liabilities 303 2,076
Loss from PIK Note Amendment and 2022 Debenture Release (3,521)
Forward purchase agreement expense (27,337)
Interest expense (1,064) (1,440)
Other income (expense), net 19 (207)
Total non-operating expense (4,263) (55,088)
Loss before income taxes (26,451) (95,255)
Provision for income taxes
Net loss (26,451) (95,255)
Deemed dividends related to the Exchange Offer and trigger of down round provisions of Assumed Warrants (3,378)
Net loss to common stockholders $ (29,829) $ (95,255)
Class A Common Stock    
Operating expenses:    
Net loss per Class A Common Stock, basic (in Dollars per share) $ (7.08) $ (84)